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Summary
Spinocerebellar ataxia type 1 (SCA1) is a neurodegen-
erative disease caused by an expanded glutamine
tract in human Ataxin-1 (hAtx-1). The expansion sta-
bilizes hAtx-1, leading to its accumulation. To un-
derstand how stabilized hAtx-1 induces selective
neuronal degeneration, we studied Drosophila Atx-1
(dAtx-1), which has a conserved AXH domain but
lacks a polyglutamine tract. Overexpression of hAtx-1
in fruit flies produces phenotypes similar to those of
dAtx-1 but different from the polyglutamine peptide
alone. We show that the Drosophila and mammalian
transcription factors Senseless/Gfi-1 interact with
Atx-1’s AXH domain. In flies, overexpression of Atx-1
inhibits sensory-organ development by decreasing
Senseless protein. Similarly, overexpression of wild-
type and glutamine-expanded hAtx-1 reduces Gfi-1
levels in Purkinje cells. Deletion of the AXH domain
abolishes the effects of glutamine-expanded hAtx-1
on Senseless/Gfi-1. Interestingly, loss of Gfi-1 mimics
SCA1 phenotypes in Purkinje cells. These results in-
dicate that the Atx-1/Gfi-1 interaction contributes to
the selective Purkinje cell degeneration in SCA1.
Introduction
Spinocerebellar ataxia type 1 (SCA1) is a neurodegen-
erative disease caused by the expansion of a translated
CAG repeat encoding glutamine in the ataxin-1 (Atx-1)
protein. This autosomal-dominant disorder typically
has its clinical onset in adulthood, when patients ex-
hibit a progressive loss of balance and coordination
and gradually develop swallowing and breathing diffi-
culties (Zoghbi and Orr, 2001). The primary sites of neu-
rodegeneration in SCA1 include cerebellar Purkinje cells
(PCs), brain-stem nuclei, the inferior olive, and the
spinocerebellar tracts. At least eight other inherited
neurodegenerative diseases, including Huntington’s dis-*Correspondence: hzoghbi@bcm.tmc.eduease (HD), are caused by a similar mutational mecha-
nism (Taroni and DiDonato, 2004; Zoghbi and Orr, 2000).
A common feature of polyglutamine (polyQ) diseases is
the loss of specific subsets of neurons in spite of broad
expression of the mutant gene product (Zoghbi and Orr,
2000). For example, both Atx-1 and huntingtin are ex-
pressed in PCs and striatal medium spiny neurons, yet
in SCA1, PCs are the prominent sites of pathology,
whereas in HD, the spiny neurons are predominantly
affected. Furthermore, although mutant Atx-1 is ex-
pressed throughout brain development, the clinical
symptoms of SCA1 appear during adulthood, suggest-
ing a temporal restriction of the pathology despite pro-
longed protein expression.
The mechanisms mediating SCA1 pathogenesis are
still not fully understood, but some general principles
have emerged. Genetic studies in mice and Drosophila
support a toxic gain-of-function mechanism. Mice lack-
ing Atx-1 do not develop ataxia or PC pathology, ar-
guing against a loss-of-function mechanism (Matilla et
al., 1998). In contrast, overexpression of mutant Atx-1
with an expanded polyQ tract causes neurodegenera-
tion in mice and flies (Burright et al., 1995; Fernandez-
Funez et al., 2000). Interestingly, even human Atx-1 with
a nonpathogenic repeat of (CAG)14CAT-CAG-CAT(CAG)15,
hereafter hAtx-1[30Q], causes neuronal degeneration if
expressed at sufficiently high levels in either mice or
Drosophila (Fernandez-Funez et al., 2000), suggesting
that protein domains other than the expanded polyQ
tract might contribute to SCA1 pathogenesis. Also, a
single serine (S776) is critical for Atx-1-induced degen-
eration, as neuronal dysfunction is dramatically damp-
ened in mice expressing a glutamine-expanded hAtx-
1[82Q] in which S776 is replaced by alanine (Emamian
et al., 2003). Phosphorylation of Atx-1 at S776 allows
the 14-3-3 protein to bind to both wild-type (wt) and
mutant Atx-1 (Chen et al., 2003). Glutamine-expanded
Atx-1 binds more strongly to 14-3-3 than wt Atx-1, and
this in turn leads to the accumulation of mutant Atx-1 and
enhances neurotoxicity in the SCA1 Drosophila model.
These data indicate that regions outside the polyQ ex-
pansion are critical for SCA1 pathogenesis.
Several reports have suggested that Atx-1 may play a
role in the regulation of gene expression. First, genetic
studies in mice have shown that nuclear localization
of mutant Atx-1 is critical to the course of the disease
(Klement et al., 1998). Second, alterations in gene ex-
pression occur very early in SCA1-transgenic mice,
prior to the onset of any detectable neurological or
pathological changes (Lin et al., 2000; Serra et al., 2004).
Third, heterozygosity for loss-of-function alleles of sev-
eral genes encoding transcriptional coregulators, in-
cluding Sin3A, Rpd3, dCtBP, and dSir2, enhances the
neurodegeneration in a SCA1 Drosophila model (Fer-
nandez-Funez et al., 2000). Lastly, several reports have
suggested that Atx-1 may interact with or modulate the
function of transcriptional coregulators, including
polyQ binding protein 1 (PQBP1) and silencing media-
tor of retinoid and thyroid hormone receptors (SMRT)
(Okazawa et al., 2002; Tsai et al., 2004). How these in-
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634teractions might contribute to the disease process and
how they might cause toxicity in only a subset of neu-
rons in SCA1 is not fully understood.
To gain insight into how Atx-1’s function contributes
to SCA1 pathogenesis, we studied the Drosophila Atx-1
homolog (dAtx-1), which lacks a polyQ tract, and com-
pared its in vivo effects and interactions to those of the
human protein. Here we show that overexpression of
hAtx-1 induces phenotypes similar to those of dAtx-1
overexpression but distinct from those observed upon
overexpression of polyQ chains in flies. Furthermore,
we identify the Drosophila zinc-finger transcription fac-
tor Senseless (Sens) and its mammalian homolog
growth factor independence-1 (Gfi-1) as physical and
genetic interactors of Drosophila and mammalian Atx-1,
respectively. We propose that the Sens/Gfi-1 interac-
tion provides a mechanism for SCA1 pathogenesis and
the selective vulnerability of PCs in this disease.
Results
dAtx-1 and hAtx-1 Induce Similar Phenotypes
When Overexpressed in Flies
A 110 residue region of hAtx-1 shows sequence homol-
ogy (28% identity, 54% similarity) with a transcription
factor called HMG box containing protein-1 (HBP1) (Yee
et al., 2004). This domain of homology has been termed
the AXH (ataxin-1/HBP1) domain (SMART Database ac-
cession number SM00536) (Figure 1A) (Chen et al.,
2004). The closest homolog of hAtx-1 in Drosophila
(dAtx-1; 44% identity) is a 230 amino acid protein en-
coded by CG4547. dAtx-1 contains the AXH domain but
not a polyQ tract (Figure 1A). Phylogenetic-tree analysis
indicates that dAtx-1 shows higher sequence homology
with hAtx-1 and its paralog Atx-1-like (H.-K.C. and H.Y.Z.,
unpublished data) than with HBP1 or any other human
protein (data not shown). There is also a small protein
corresponding to the AXH domain in C. elegans, sug-
gesting that this domain serves as an independent
functional unit (Figure 1A).
To test the function of the AXH domain, we overex-
pressed dAtx-1 in flies using the GAL4/UAS system
(Brand and Perrimon, 1993) and compared its effects
to those of hAtx-1. Overexpression of dAtx-1 by Rho-
dopsin1(Rh1)-GAL4, which drives expression in the dif-
ferentiated R1–R6 photoreceptor cells (Mollereau et al.,
2000; O’Tousa et al., 1985), results in neurodegenera-
tion in the eye, as does overexpression of hAtx-1[82Q].
Although at 2 days after eclosion, overexpression of
either Atx-1 does not show obvious morphological
changes in the photoreceptor cells (data not shown),
both genotypes show many large holes and loss of cell
integrity at 28 days (Figures 1B–1D). Overexpression of
dAtx-1 using the GMR-GAL4 driver also induces eye
abnormalities. The external structures of the eyes that
overexpress dAtx-1 show disorganized ommatidia and
loss of interommatidial bristles (Figure 1F), and these
eyes exhibit loss of rhabdomeres and tissue integrity
(Figure 1J). In both cases, dAtx-1 phenotypes are sim-
ilar to but milder than hAtx-1. We also found that dAtx-1
and hAtx-1 induce similar phenotypes in other tissues.
Although the GMR-GAL4 driver is mainly eye specific
(Freeman, 1996), it also induces a broad low-level ex-
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fression in the wing during the early pupal stage (Fig-
re 1L). Interestingly, expression of dAtx-1 and hAtx-
[82Q] using GMR-GAL4 generates extra wing-vein tis-
ue (Figures 1N and 1O). Similar to the eye phenotypes,
Atx-1 overexpression causes a milder phenotype.
To examine the wing phenotypes induced by Atx-1,
e overexpressed dAtx-1 in the wing pouch using C5-
AL4 (Yeh et al., 1995) and in the wing margin using
96-GAL4 (Gustafson and Boulianne, 1996). Overex-
ression of dAtx-1 using the wing-pouch driver at 27°C
auses several vein abnormalities (Figure 1R). Overex-
ression of hAtx-1[82Q] at 27°C has a more severe phe-
otype and causes an atrophic wing (Figure 1S). When
lies overexpressing hAtx-1 are incubated at 23°C to
ower the level of hAtx-1[82Q] expression, we observe
phenotype similar to that of dAtx-1 (inset in Figure
S). With the wing-margin driver, both dAtx-1 and hAtx-
[82Q] cause bristle abnormalities including patterning
efects (Figures 1V and 1W, arrows) and bristle loss
Figure 1W, brackets). We compared the effects of five
Atx-1-, two hAtx-1[30Q]-, and three hAtx-1[82Q]-
ransgenic lines, using the GMR-GAL4, the wing-pouch,
r the wing-margin drivers. Even the strongest dAtx-1
ransgenes show milder phenotypes than the weakest
uman Atx-1[30Q] (data not shown) or hAtx-1[82Q]
ransgenes (Figure 1). Consistent with our previous re-
ort (Fernandez-Funez et al., 2000), the phenotypes of
Atx-1[30Q] are also milder than those of hAtx-1[82Q]
data not shown).
The polyQ chain alone has been shown to cause cy-
otoxicity (Kazemi-Esfarjani and Benzer, 2000; Marsh et
l., 2000). To confirm that the Atx-1-induced toxicity is
XH-domain mediated and distinct from the polyQ
ract, we compared phenotypes induced by a polypep-
ide comprised of 127 glutamines (127Q) (Kazemi-
sfarjani and Benzer, 2000) to those induced by Atx-1.
lthough overexpressing 127Q using GMR-GAL4 re-
ults in a more severe eye phenotype than dAtx-1 over-
xpression (Kazemi-Esfarjani and Benzer, 2000) (Figure
H), flies overexpressing 127Q do not show extra veins
n the wing (Figure1P). Overexpression of 127Q using
he wing-pouch driver does not cause significant vein
bnormalities, although it induces a mild wing atrophy
t 29°C (Figure 1T). Furthermore, overexpression of
27Q with the wing-margin driver does not cause pat-
erning defects as observed with Atx-1 overexpression
Figure 1X). Because hAtx-1 induces phenotypes sim-
lar to dAtx-1 and since these phenotypes are not in-
uced by the polyQ tract, we conclude that the polyQ
ract is not necessary to generate the gain-of-function
henotype of Atx-1 in flies.
rosophila and Mammalian Ataxin-1 Physically
nteract with Sens and Gfi-1
ased on the similar phenotypes of dAtx-1 and hAtx-1
n Drosophila (Figure 1), we hypothesized that some of
he aberrant signaling may be conserved between
Atx-1 and hAtx-1. We focused on the bristle pheno-
ypes. Bristles are mechanosensory organs of the pe-
ipheral nervous system (PNS) that develop from epi-
ermal cells through the coordinated activities of
roneural proteins and Sens, a zinc-finger transcription
actor required for the generation of sensory organs in
SCA1 Antagonizes Gfi-1/Senseless Function
635Figure 1. Drosophila and Human Atx-1[82Q] Overexpression Phenotypes
(A) Proteins of the Atx-1 family and HBP1 show high-percentage amino acid identity to hAtx-1 in the AXH domain (solid boxes).
(B–D) Overexpression of Atx-1 using Rh1-GAL4 causes degeneration in photoreceptor cells. Toluidine-blue-stained eye sections of Canton S (CS)
(B), Rh1-GAL4/+; UAS-datx-1/+ (C), Rh1-GAL4/+; UAS-hatx-1[82Q]/+ (D) at 28 days posteclosion are shown. In flies overexpresing dAtx-1, five or
six photoreceptor cells remain out of the eight found in normal eyes, whereas in flies overexpressing hAtx-1[82Q] only one or two photoreceptors
remain.
(E–K) Expression of Atx-1 or 127Q driven by GMR-GAL4 leads to eye abnormalities. (E)–(H) are SEM eye images; (I)–(K) are internal eye structures.
GMR-GAL4/+ control (E and I), GMR-GAL4/+; UAS-datx-1/+ (F and J), GMR-GAL4/+; UAS-hatx-1[82Q]/+ (G and K), GMR-GAL4/+; UAS-127Q/+ (H).
(L) GFP fluorescence in the wing of GMR-GAL4/+; UAS-GAL4/+; UAS-CD8-GFP during the early pupal stage. UAS-GAL4 was used to increase
the GAL4 protein levels.
(M–P) Expression of dAtx-1 and hAtx-1[82Q] in the wing under the control of GMR-GAL4 causes wing-vein abnormalities, whereas that of 127Q
does not. Wings of GMR-GAL4/+ control (M), GMR-GAL4/+; UAS-datx-1/+ (N), GMR-GAL4/+; UAS-hatx-1[82Q]/+ (O), and GMR-GAL4/+; UAS-
127Q/+ (P) are shown. Regions of magnification are shown in insets.
(Q–T) Atx-1 expressed by a wing-pouch driver (C5-GAL4) shows wing-vein abnormalities, including extra veins (arrowheads) and truncation
of normal veins (arrow). Expression of 127Q using C5-GAL4 does not cause wing-vein abnormalities. Wings of flies overexpressing LacZ (Q),
dAtx-1 (R), hAtx-1[82Q] (S), and 127Q (T) raised at 27°C are shown. Wing of a fly overexpressing hAtx-1[82Q] at 23°C is shown in the inset
in (S).
(U–X) Overexpression of Atx-1 but not 127Q causes patterning defects (arrows) and loss of bristles (brackets) in the wing margin. Wing
margins of flies overexpressing LacZ (U), dAtx-1 (V), hAtx-1[82Q] (W), and 127Q (X) are shown. In all cases, hAtx-1[82Q] overexpression
causes a more severe phenotype than dAtx-1 overexpression.flies (Nolo et al., 2000; Bertrand et al., 2002). Interest-
ingly, we found that dAtx-1 interacts with Sens in a
yeast two-hybrid screen aimed at identifying Sens-
interacting proteins (Figure 2A). To determine which do-
main of dAtx-1 can bind Sens, we performed two-hybrid
interaction assays using dAtx-1 deletion constructs. As
shown in Figures 2A and 2C, residues 100 through 154,
a part of the AXH domain, of dAtx-1 are necessary and
sufficient for the interaction with Sens. To confirm the
interaction, we performed coimmunoprecipitation (CoIP)
assays using FLAG-tagged dAtx-1 and HA-tagged
Sens in COS7 cells. Monoclonal anti-FLAG or anti-HA
antibody immunoprecipitates Sens or dAtx-1, respec-
tively, only when FLAG-dAtx-1 and HA-Sens are coex-
pressed (Figure 2D). Together, these data indicate that
dAtx-1 physically interacts with Sens.As shown in Figure 2A, hAtx-1 also interacts with
Sens in yeast. Given the structural and functional sim-
ilarities between Sens and its vertebrate homolog Gfi-1
(Jafar-Nejad and Bellen, 2004), we then asked whether
hAtx-1 binds Gfi-1 (Gilks et al., 1993). As shown in Fig-
ure 2B, Gfi-1 interacts with hAtx-1[2Q] or [82Q] based
on a yeast two-hybrid assay as well as CoIP studies in
transfected cells (data not shown). The AXH subdomain
of hAtx-1 (residues 631–685 corresponding to residues
100–154 in the fly) is necessary and sufficient to interact
with Gfi-1 (Figures 2B and 2C). To confirm the direct
interaction between Atx-1 and Gfi-1, we assessed the
ability of GST-hAtx-1 to pull down Gfi-1 protein. As
shown in Figure 2E, while GST-hAtx-1[2Q] and GST-AXH
domain can pull down Gfi-1 protein, GST-hAtx-1[2Q]
lacking AXH domain fails to interact with Gfi-1, sug-
Cell
636Figure 2. dAtx-1 and hAtx-1 Interact with Sens and Gfi-1, Respectively
(A–C) Sens and dAtx-1 (A) and Gfi-1 and hAtx-1 (B) interaction in a yeast two-hybrid assay. BD, DNA binding domain; AD, activation domain.
Double transformants were selected on -Trp/-Leu/-His/-Ade (-W/-L/-H/-A) media. (C) shows a schematic diagram of Atx-1 constructs and
their interaction with Sens and Gfi-1.
(D) FLAG-tagged dAtx-1 and HA-tagged Sens coimmunoprecipitate from transfected COS7 cells. IP, immunoprecipitate.
(E) GST pull-down assays show that Gfi-1 can bind hAtx-1[2Q] and AXH domain but not hAtx-1[2Q] lacking the AHX domain.
(F) Mouse Atx-1 and Gfi-1 coimmunoprecipitate from cerebellar extracts of wt mice (left) but not atx-1 knockout mice. The immunoprecipita-
tion was done with anti-Atx-1 and immunoblotting with anti-Gfi-1 antibody.gesting that the AXH domain mediates the direct in-
teraction between the two proteins. To find the recipro-
cal domain of Sens/Gfi-1 that binds Atx-1, we tested
deletion constructs for their ability to bind dAtx-1 or
hAtx-1. As shown in Figures S1A and S1B in the Sup-
plemental Data available with this article online, the
amino-terminal regions, not the zinc-finger domain of
Sens or Gfi-1, are sufficient for the interaction with
dAtx-1 or hAtx-1, respectively. Lastly, to confirm the in-
teraction in vivo, we performed CoIP assays using
mouse brain extracts. The anti-Atx-1 antibody coimmu-
noprecipitates Gfi-1 from brain extracts of wt mice but
not from extracts of atx-1 null mice (Matilla et al., 1998)
(Figure 2F), indicating that the two proteins interact
in vivo. In summary, our data indicate that dAtx-1 and
hAtx-1, via the AXH domain, can bind to Sens and
Gfi-1, respectively.
Sens and Gfi-1 Are Coexpressed with Atx-1
Homologs in Drosophila and Mice
The findings that fly Atx-1 and Sens as well as mamma-
lian Atx-1 and Gfi-1 physically interact prompted us to
examine if Atx-1 and Sens/Gfi-1 are coexpressed in vivo.
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tn situ hybridization and Northern analyses show that
atx-1 is expressed in embryonic stages (Figures 3A–
D and data not shown). The expression of datx-1 is
irst observed in the dorsolateral region in the stage 5
mbryos (Figure 3A). During gastrulation, datx-1 is ex-
ressed in the dorsolateral ectoderm that encom-
asses the peripheral neuroectoderm (Figure 3B). sens
RNA is first expressed in presumptive sensory organ
recursor (SOP) cells at stage 10 (Nolo et al., 2000). We
ound that sens is expressed in a subset of cells within
he region of datx-1 expression (Figures 3C and 3D). In
ice, Gfi-1 is expressed in many areas that give rise to
euronal cells during embryonic development (Wallis et
l., 2003). However, our data show that, in the adult
erebellum, Gfi-1 expression is mainly confined to PCs,
here Atx-1 is most abundant (Figures 3E–3G) (Banfi et
l., 1996).
taxin-1 Inhibits Sens Function
uring SOP Formation
o address the relevance of the biochemical interac-
ions between Atx-1 and Sens, we examined the func-
ional relationship between these proteins in vivo. Sens
SCA1 Antagonizes Gfi-1/Senseless Function
637Figure 3. Fly and Mouse Atx-1 Colocalize with Sens and Gfi-1 in Certain Cell Types
(A–D) Temporal and spatial expression of datx-1 analyzed by whole-mount in situ hybridization. (A) shows blastula stage, lateral view; (B)
shows gastrula stage, lateral view; (C) and (D) show germband elongation stage, lateral view. (D) is a higher magnification of (C).
(E–G) Gfi-1 and Atx-1 are coexpressed in PCs. Double staining of a cerebellar section from an 8-week-old mouse with anti-Gfi-1 (E) and anti-
Atx-1 (F) antibodies. (G) is the merged image.is directly activated by the proneural proteins in the
presumptive SOPs, where it acts as a transcriptional
activator and synergizes with proneural proteins (Jafar-
Nejad et al., 2003). Overexpression of Sens, using the
Scabrous (C109-68-GAL4) driver (Abdelilah-Seyfried et
al., 2000), in the SOPs and a few cells around them
causes extra bristle formation—microchaetae and
macrochaetae—in the thorax of the adult fly (Figure
4D). In contrast, overexpression of either dAtx-1 or
hAtx-1 using the Scabrous driver causes loss of tho-
racic bristles (Figures 4B and 4C), with human Atx-
1[82Q] causing a more severe phenotypes (Figures 4B,
4C, and 4G). When dAtx-1 and Sens are coexpressed
in SOPs, Sens overexpression abolishes the phenotype
of dAtx-1 overexpression (Figures 4E and 4G). Similarly,
Sens overexpression suppresses the loss-of-bristle
phenotype induced by hAtx-1[82Q], although the num-
ber of extra bristles is decreased compared to Sens
overexpression alone (Figures 4F and 4G). These data
suggest that Atx-1 overexpression phenotype may re-
sult from an alteration in Sens expression or function.
Sens synergizes with Achaete (Ac) to promote bristle
formation in the thorax. Previously, an in vitro transcrip-
tion assay, using the proximal ac promoter as the repor-
ter, was established that recapitulates the in vivo activ-
ity of Sens in SOPs (Jafar-Nejad et al., 2003). Sens
alone does not activate the ac promoter (data not
shown). Cotransfection of Ac and Daughterless (Da) ex-
pression constructs activates the promoter about 50-
fold. Adding Sens leads to a further activation of the
ac promoter (150-fold), indicating synergism between
Sens and these proneural proteins (Figure 4J). To refinethe molecular basis of Atx-1’s effect on bristle forma-
tion, we examined its activity in this transcription assay.
Adding dAtx-1 does not have a significant effect on the
ac promoter directly (Figure 4H) or on Ac/Da activity
(Figure 4I). However, dAtx-1 suppresses the synergism
between Sens and Ac/Da in a dose-dependent manner
(Figure 4J). Furthermore, this effect on Sens activity is
more potent with the mammalian Atx-1 homologs. As
shown in Figure 4K, lesser amounts of hAtx-1[2Q] or
[82Q] are required to inhibit Sens activity when com-
pared to dAtx-1 (Figure 4J). Together, our in vivo and in
vitro data strongly suggest that overexpression of Atx-1
inhibits the activity of Sens in the SOP formation.
Atx-1 Decreases the Level of Sens Protein
in a Cell-Autonomous Manner
To explore the mechanism by which Atx-1 suppresses
Sens function, we evaluated the levels of Sens protein
in wing imaginal discs, where it is expressed in the
SOPs (Figure 5A) (Nolo et al., 2000). Using the Scabrous
driver, we found that overexpression of either fly or hu-
man Atx-1 decreases the level of endogenous Sens
protein (Figures 5A–5C). Consistent with the bristle
phenotypes, overexpression of hAtx-1[82Q] has a more
severe effect on Sens levels than dAtx-1 (Figures 5B
and 5C). Overexpression of Atx-1 using GMR-GAL4
also suppresses Sens protein levels in the R8 photore-
ceptor cells (data not shown), where Sen is expressed
(Frankfort et al., 2001).
We then assessed whether Atx-1 exerts its activity
on Sens in a cell-autonomous manner. In the wing mar-
gin, Sens is expressed in several rows of cells flanking
Cell
638Figure 4. Atx-1 Inhibits the Function of Sens In Vivo and In Vitro
(A–F) Atx-1 inhibits bristle formation.
(A) Thorax of a CS fly.
(B–D) Thoraxes of flies expressing dAtx-1 (B), hAtx-1[82Q] (C), or Sens (D) under the control of the C109-68-GAL4 driver. Atx-1 causes loss
of macrochaetae (arrow) and microchaetae, whereas Sens induces extra bristles.
(E and F) The effect of Sens overcomes those of dAtx-1 (E) and hAtx-1[82Q] (F).
(G) Quantification of the number of macrochaetae shown in panels (A)–(F). Error bars indicate 95% confidence interval.
(H–K) Transcription assay in S2 cells using an enhancer/promoter fragment of the ac gene to drive luciferase. Error bars indicate standard
error of the mean.
(H and I) The effects of dAtx-1 on the ac promoter in the absence (H) or presence of Ac/Da (I). Note that even 180 ng of datx-1 does not have
a significant effect in the absence of Sens.
(J) dAtx-1 suppresses the synergism of Sens and Ac/Da in a dose-dependent manner.
(K) 15 ng of hAtx-1[2Q] or [82Q] suppresses the activity of Sens. Note that the effect of 15 ng of either hAtx-1 is comparable to that of 60 ng
dAtx-1.the dorsoventral margin, where the Wingless gradient
is at its peak (Figures 5E–5G). Sens expression in these
cells, which will give rise to wing-margin SOPs, is thought
to be dependent on Wingless (Parker et al., 2002). As
shown in Figures 5J and 5L, overexpression of hAtx-
1[82Q] using the dpp-GAL4 driver causes a loss of
Sens protein, but the cells flanking the hAtx-1 overex-
pression domain are not affected (Figures 5I–5L). Fur-
thermore, Wingless expression in the wing margin is
not decreased in the cells in which hAtx-1 is overex-
pressed (Figure 5K and arrow in Figure 5L). These data
demonstrate that the effects of Atx-1 on Sens are cell
autonomous. Overexpression of dAtx-1 using the dpp-
GAL4 driver also decreases the level of Sens (data not
shown). Furthermore, the effect of hAtx-1[82Q] on Sens
levels is not merely due to the expanded polyQ tract,
as overexpression of 127Q or hAtx-1[82Q] lacking AXH
domain has no significant effects on Sens levels (Fig-
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sures 5N–5Q).To determine whether the loss of Sens in the Atx-1
verexpression domain is due to cell death or decreased
ens transcription, we examined the level of sens RNA
n the wing margin with or without Atx-1 overexpres-
ion. In situ hybridization for sens showed that Atx-1
verexpression does not affect sens mRNA levels (Fig-
re 5M), suggesting an effect at the protein level and
uling out cell death as a cause. The direct physical
nteraction between Atx-1 and Sens raises the possi-
ility that Atx-1 might cause the Sens protein to be-
ome unstable.
fi-1 Expression Is Decreased in SCA1-Transgenic
ice in the Absence of Notable Cell Death
oes the in vivo effect of Atx-1 in fly SOPs have a func-
ional correlate in mammals? To answer this question,
e determined the consequences of Atx-1 overexpres-
ion on Gfi-1 levels in PCs. We examined Gfi-1 levels
in mice that overexpress hAtx-1[82Q] only in PCs.
SCA1 Antagonizes Gfi-1/Senseless Function
639Figure 5. Atx-1 Overexpression Decreases Sens Protein Levels in a Cell-Autonomous Manner
(A–C) Atx-1 expression driven by C109-68-GAL4 suppresses endogenous Sens protein. Wing imaginal discs from flies expressing LacZ (A),
dAtx-1 (B), and hAtx-1[82Q] (C) stained with anti-Sens antibody are shown.
(D–M) hAtx-1[82Q] decreases Sens protein, not mRNA. dpp-GAL4 was used to drive the expression of LacZ (D–H) and hAtx-1[82Q] (I–M)
along the anterior-posterior boundary in the wing imaginal disc. Staining with anti-β-gal (D), anti-Atx-1 (I), anti-Sens (E and J), and anti-
Wingless (F and K); merged images (G and L); and whole-mount in situ hybridization for sens mRNA expression (H and M) are shown.
Overexpression of hAtx-1[82Q] using the dpp-GAL4 driver decreases Sens protein (arrow in [J] and [L]) but not Wingless protein (K and L) or
sens mRNA levels (M).
(N–Q) Overexpression of 127Q or hAtx-1[82Q] lacking AXH domain does not have significant effects on Sens expression. dpp-GAL4/+; UAS-
HA-127Q/+ (N and O). dpp-GAL4/+; UAS-hAtx-1[82Q]AXH(-)/+ (P and Q). Staining is with anti-HA (N), anti-hAtx-1 (P), and anti-Sens (O and Q).These mice develop ataxia after 5 weeks of age and
show significant loss of PCs after 6 months (Burright et
al., 1995; Clark et al., 1997). We observed a marked
decrease in Gfi-1 protein levels in PCs of these mice
compared to wt mice (Figures 6B and 6E). The de-
crease in Gfi-1 protein levels occurs at a time when
there is no significant loss of PCs, as determined by
calbindin staining (Figure 6D). Lastly, to confirm that the
effect of hAtx-1 on Gfi-1 is indeed mostly due to se-
quences other than the glutamine tract, we evaluated
Gfi-1 levels in mice overexpressing wt hAtx-1[30Q].
These mice, when bred to homozygosity and aged, de-
velop Purkinje cell degeneration. Here again, we find
Gfi-1 levels to be decreased (Figures 6J–6L), suggest-
ing that the functional and physical interactions of Atx-1
and Sens/Gfi-1 are conserved between Drosophila
and mice.
Atx-1 Destabilizes Gfi-1 by Enhancing Its
Degradation via the Proteasome
To explore the mechanism by which Atx-1 reduces Gfi-1
levels, we examined the effect of Atx-1 on the degrada-tion of Gfi-1. We used pulse-chase radiolabeling analy-
sis to evaluate the stability of endogenous Gfi-1. About
72% of the labeled Gfi-1 remains in control cells after
2 hr. However, in cells which express dAtx-1 or hAtx-
1[82Q], Gfi-1 is less stable (46% and 31% remaining,
respectively). Gfi-1’s stability is not affected in cells that
expressed hAtx-1[82Q] lacking the AXH domain (78%
remaining) (Figures 6M and 6N). These data suggest
that Atx-1 enhances the degradation of Gfi-1 upon in-
teraction via its AXH domain.
To determine if Gfi-1’s degradation is dependent on
the proteasome, we examined the effect of proteasome
inhibition on the stability of Gfi-1. Whereas mock-
treated cells have no Gfi-1 immunofluorescence 72 hr
after transient transfection of Gfi-1 expression vector,
proteasome-inhibitor-treated cells accumulate Gfi-1
(Figure S2D). Moreover, accumulated Gfi-1 colocalizes
with the 20S proteasome (Figures S2D–S2F), suggest-
ing that Gfi-1 degradation is via the proteasome path-
way. We next examined whether inhibiting the protea-
some can interfere with the effect of Atx-1 on Gfi-1
stability. Treatment of cells with proteasome inhibitor
Cell
640Figure 6. The Effects of Atx-1 on Gfi-1 Level In Vivo and In Vitro
(A–L) Gfi-1 levels are markedly decreased in both Atx-1[82Q]- and Atx-1[30Q]-transgenic mice (atx-1[82Q]Tg/+ and atx-1[30Q]Tg/[30Q]Tg) even in
the absence of cell loss. Cerebellar slices from a 5-week-old wt mouse (A–C), a 5-week-old Atx-1[82Q]-transgenic mouse (D–F), a 54-week-
old wt mouse (G–I), and a 48-week-old Atx-1[30Q]-transgenic mouse (J–L) are shown. Staining is with anti-calbindin (A, D, G, and J) and anti-
Gfi-1 (B, E, H, and K) antibodies; (C), (F), (I), and (L) are the merged images.
(M–O) The pulse-chase assays show that Atx-1 destabilizes Gfi-1 in the BE-2 human neuroblastoma cell line.
(M) Representative autoradiographs of 35S-labeled endogenous Gfi-1 protein in BE-2 cells transiently transfected with empty vector, dAtx-1,
hAtx-1[82Q], or hAtx-1[82Q] lacking AXH domain.
(N) Amount of radiolabeled Gfi-1 remaining after the indicated time points in the pulse-chase assays. Gfi-1 is less stable in cells that express
dAtx-1 and hAtx-1[82Q] but not in cells that express hAtx-1[82Q] lacking the AXH domain. Error bars indicate standard error of the mean.
(O) Autoradiographs of 35S-labeled endogenous Gfi-1 protein in BE-2 cells after a 4 hr incubation period in unlabeled medium with the
presence of β-lactone or DMSO. β-lactone increases the radiolabeled Gfi-1 in cells transfected with Atx-1[82Q] by 56% compared with DMSO.leads to the accumulation of Gfi-1 in the hAtx-1[82Q]
transfected cells, suggesting that hAtx-1 enhances
Gfi-1 degradation via the proteasome pathway (Fig-
ure 6O).
Loss of Gfi-1 Leads to Purkinje Cell Degeneration
Gfi-1 heterozygous mice are viable and fertile (Hock et
al., 2003) and display no overt cerebellar phenotypes
based on the accelerating-rotarod analysis and cere-
bellar histochemistry (Wallis et al., 2003 and data not
shown). Gfi-1 null mice display loss of the cochlear hair
cells and aberrant differentiation of vestibular hair cells,
and they exhibit several behavioral abnormalities, in-
cluding severe ataxia (Wallis et al., 2003). Since either
vestibular or cerebellar defects can cause ataxia, we
evaluated the cerebellar phenotype of Gfi-1 null mice
by immunohistochemistry. The overall gross morphol-
ogy of the cerebellum is normal in adult Gfi-1 null mice
(data not shown). Calbindin staining of cerebellar sec-
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dions from 11-week-old Gfi-1 null mice reveals a normal
umber of PCs (Figure 7D). However, at 6 months of
ge, Gfi-1 null mice display a loss of PCs (Figure 7E).
n addition, most of the surviving PCs exhibit abnormal
uclear and cytoplasmic morphology (arrowheads in
igure 7F) in the soma and aberrant and disorganized
endrites (Figure 7F). The axons of the PCs have focal
wellings (arrow in Figure 7F), similar to what has been
eported in SCA1 patients (Zoghbi and Orr, 2001). The
bservation that loss of PCs appears several months
ostnatally argues against a developmental defect and
ndicates that Gfi-1 contributes to survival of PCs. In
ummary, the cerebellar pathology in Gfi-1mutant mice
trongly suggests that alterations in the level of Gfi-1 may
ccount in part for the PC-specific phenotype of SCA1.
oss of One Copy of Gfi-1 Enhances
he Pathogenesis of SCA1
Atx-1[82Q]-transgenic mice display progressive den-
ritic and somatic atrophy of PCs prior to cell death
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641Figure 7. Gfi-1 Loss Contributes to Purkinje
Cell Degeneration
Calbindin staining in PCs from wt (A–C) and
Gfi-1 null mice (D–F), 11 weeks of age (A and
D) and 26 weeks of age (B, C, E, and F), is
shown. wt (A) and Gfi-1 null mice (D) have
similar PC morphology at 11 weeks of age.
By 26 weeks, Gfi-1 null mice (E and F) show
abnormal nuclear and cytoplasmic morphol-
ogy (arrowheads), disorganized dendritic ar-
borization, swollen axons (arrows), and loss
of PCs. The molecular layer (ml), PC layer
(pcl), and granule-cell layer (gcl) are indi-
cated in (C) and (F). As shown in (G), calbin-
din staining is decreased in PCs of hAtx-
1[82Q] lacking one allele of Gfi-1 (p < 0.001).
Quantitative analysis of calbindin immuno-
fluorescence is an indirect measure of PC
soma and dendritic integrity.(Clark et al., 1997). To examine the role of Gfi-1 in SCA1
pathogenesis, we evaluated the effects of heterozygos-
ity for a loss-of-function allele of Gfi-1 in PCs in which
Atx-1 is overexpressed. Interestingly, hAtx-1[82Q]-
transgenic mice that lack one functional copy of Gfi-1
show a worsening of their PC pathology at 8 weeks of
age as quantified by measuring calbindin immunofluo-
rescence in the soma and dendrites of PCs (Figure 7G).
Furthermore, these mice perform more poorly on the
accelerating-rotarod apparatus at 4 weeks of age as
compared to mice having the hAtx-1[82Q] transgene in
a wt Gfi-1 background (data not shown). The dosage-
dependent genetic interaction between atx-1 and Gfi-1,
together with the decreased level of Gfi-1 in the hAtx-
1[82Q]-transgenic mice, strongly suggests that decreas-
ing the level of Gfi-1 by mutant Atx-1 mediates or con-
tributes to SCA1 pathogenesis.
Discussion
The expanded glutamine tract is clearly the initiating
event in the pathogenesis of polyQ neurodegenerativedisorders. In SCA1 and related disorders, the length of
the glutamine tract correlates inversely with the age of
onset and directly with the severity of the phenotype.
Overexpression of a polyQ peptide in cell-culture, inver-
tebrate, and mouse models is quite toxic and causes
progressive dysfunction and cell death. However, there
are several pieces of data that argue that the expanded
glutamine tract is not the sole factor that induces pa-
thology and determines disease severity. For example,
several genetic studies support the idea that se-
quences outside of the glutamine tract are critical for
causing neurodegeneration phenotypes in SCA1. First,
overexpression of wt hAtx-1[30Q] in flies and mice
causes pathology (Fernandez-Funez et al., 2000). Sec-
ond, replacing serine 776 with an alanine in Atx-1[82Q]
dampens SCA1 pathology (Emamian et al., 2003). Also,
a CAG repeat length of 45 causes severe disease in
SCA2, mild disease in SCA1, and no symptoms in SCA3
(Zoghbi and Orr, 2000). These genotype-phenotype
correlation studies argue that protein sequences out-
side of the glutamine tract as well as protein-protein
interactions are critical for pathology.
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642Our data indicate that hAtx-1 induces phenotypes
similar to (but more severe than) those of dAtx-1 and
distinct from those induced by overexpression of a
polyQ peptide. The effects of hAtx-1[82Q] on Sens/
Gfi-1 protein levels are abolished in the absence of the
AXH domain in both flies and mammalian cells. Further-
more, overexpression of wt hAtx-1[30Q] in mice de-
creases Gfi-1 levels and induces degeneration. This is
noteworthy given that the 30Q allele does not contain
30 consecutive Qs but is comprised of two stretches of
14 and 15 Qs interrupted by two histidine residues.
These data collectively argue that the AXH domain but
not the expanded polyQ tract is necessary to generate
the Atx-1 gain-of-function phenotype in flies or mice.
The findings that glutamine-expanded hAtx-1 produces
more severe phenotypes than wt hAtx-1 and dAtx-1
suggest that the polyQ tract enhances the activity of
the AXH domain in a quantitative and/or qualitative
manner.
Because the AXH domain is the likely mediator of the
effects of Atx-1 overexpression, the prediction would
be that this domain might mediate the biochemical and
genetic interactions that modulate or contribute to the
SCA1 phenotypes. Indeed, our data on the genetic and
biochemical interactions of fly and hAtx-1 proteins with
Drosophila Sens and its mammalian homolog Gfi-1
strongly support this prediction. The finding that the
AXH domain of dAtx-1/hAtx-1 is necessary and suffi-
cient for physical interactions with Sens/Gfi-1 underscores
the cross-species functional conservation of this do-
main and the potential role of Sens/Gfi-1 in mediating
Atx-1-induced phenotypes. In support of Atx-1’s spe-
cific effect on Sens, we find that (1) Atx-1 has direct
effects on Sens protein (not RNA) levels through the
AXH domain; (2) Atx-1 antagonizes the activity of Sens,
not that of Ac or Da, in a transcription assay; and (3)
Sens overexpression suppresses the Atx-1-induced
bristle phenotypes in flies. Similarly, hAtx-1 and Gfi-1
also genetically interact in mice, as evidenced by the
worsening of PC pathology in a background heterozy-
gous for a Gfi-1 loss-of function allele. Moreover, hAtx-1
reduces Gfi-1 protein levels in the absence of cell loss.
Exactly how Atx-1 promotes the degradation of Sens/
Gfi-1 is not known at this time, but our data suggest
that Atx-1 enhances the proteasome-mediated degra-
dation of Gfi-1. We propose that Atx-1 and Sens/Gfi-1
interactions alter the conformation, modification, or
other protein interactions of Sens/Gfi-1, rendering them
less stable.
Gfi-1 Is Necessary for the Survival of Purkinje Cells
Given the decline of Gfi-1 levels in PCs of SCA1-trans-
genic mice, a key question is whether this decrease
contributes to SCA1 pathogenesis. Indeed, we find that
loss of Gfi-1 phenocopies SCA1 and causes PC degen-
eration after several months of normal PC develop-
ment. Furthermore, loss of one allele of Gfi-1 enhances
the motor-incoordination phenotype of SCA1 mice at 4
weeks of age, well before the PCs of these mice de-
velop obvious morphological changes (Burright et al.,
1995; Clark et al., 1997). These data, together with the
finding that Gfi-1 and Atx-1 physically interact, highlight
the important role of Gfi-1 in PC degeneration and
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(CA1 pathogenesis. The finding that a transcriptional
egulator like Gfi-1 is a major modifier of SCA1 pheno-
ypes and an interactor of Atx-1 is interesting given the
roposal that Atx-1 might function in the regulation of
ene expression (Lin et al., 2000; Serra et al., 2004).
athogenic Mechanisms in SCA1: Relevance
o Other Neurodegenerative Diseases
everal neurodegenerative diseases are caused by a
ain-of-function mutational mechanism, which renders
he host protein toxic to neurons. Examples include
utations in amyloid precursor protein (APP) causing
lzheimer’s disease (AD) (Mattson, 2004), mutations in
au causing frontotemporal dementia (FTD) (Hutton et
l., 1998), and mutations in α-synuclein causing Parkin-
on’s disease (PD) (Vila and Przedborski, 2004). It is
nteresting that an extra dose of wt APP in Down’s syn-
rome causes early onset AD-like changes (Mrak and
riffin, 2004) and that duplications as well as triplica-
ions of wt α-synuclein cause PD (Chartier-Harlin et al.,
004; Ibanez et al., 2004; Singleton et al., 2003). Our
inding that overexpression of wt Atx-1 causes neuro-
egeneration is reminiscent of these observations. In
act, accumulation of wt Atx-1 has been noted in pa-
ients with neuronal intranuclear inclusion disease in
he absence of a CAG expansion of the SCA1 gene
Lieberman et al., 1999). These data collectively sug-
est that higher than wt levels of proteins such as
tx-1 or α-synuclein are toxic to specific groups of neu-
ons. We propose that expansion of the glutamine tract
n Atx-1 (and possibly other polyQ proteins) will stabi-
ize them and/or enhance their interaction with other
roteins. Thereby, enhancement of wt functions results
n the neurodegeneration.
To date, several Atx-1-interacting proteins have been
dentified, including leucine-rich acidic nuclear protein,
QBP1, and SMRT (Matilla et al., 1997; Okazawa et al.,
002; Tsai et al., 2004). Gfi-1 is the first protein to fulfill
he criteria to be a mediator of the SCA1 pathogenesis:
t interacts physically and genetically with Atx-1 (as do
he fly orthologs), loss of Gfi-1 copies the SCA1 pheno-
ype in PCs, and Gfi-1 and SCA1 show a dose-depen-
ent interaction. The molecular mechanisms described
n the current study underscore the importance of
tudying the wt function and interactors of proteins in-
olved in neurodegenerative diseases.
xperimental Procedures
or details on GST pull-down assays, IP, Western blotting analysis,
nd yeast two-hybrid assays, see Supplemental Experimental Pro-
edures.
ly Strains
ly strains used were y w, Canton S (Bloomington Stock Center),
AS-human atx-1[82Q] (F7, N35Y, M6), [30Q] (F1, F7) (Fernandez-
unez et al., 2000), UAS-127Q (Kazemi-Esfarjani and Benzer, 2000),
AS-sens (C12) (Nolo et al., 2000), Rh1-GAL4 (Mollereau et al.,
000), GMR-GAL4 (Freeman, 1996), C5-GAL4 (Yeh et al., 1995),
96-GAL4 (Nolo et al., 2001), C109-68-GAL4 (Abdelilah-Seyfried et
l., 2000), dpp-GAL4/TM6B (G. Mardon, Houston), UAS-lacZ (Nolo
t al., 2001), UAS-GAL4 (Hassan et al., 2000), and UAS-mCD8-GFP
Dubruille et al., 2002).
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Primary antibodies were as follows: Guinea pig anti-Sens (1:800)
(Nolo et al., 2000), mouse anti-β-gal (1:1000) (Promega), rabbit anti-
Atx-1 (117650VII or 11NQ) (Matilla et al., 1998; Skinner et al., 1997),
Guinea pig anti-Gfi-1 (1:1000) (Wallis et al., 2003), mouse anti-Wing-
less (1:10) (Developmental Studies Hybridoma Bank), anti-calbindin
(1:1000) (Sigma), and anti-20S proteasome (1:500) (Affiniti Re-
search). Secondary antibodies were as follows: Alexa 488-anti-
Guinea pig (1:500) (Molecular Probes) and Cy3-anti-Guinea pig
(1:500), Cy3-anti-rabbit (1:500), Cy3-anti-mouse (1:500), and Cy5-
anti-rabbit (1:500) (Jackson ImmunoResearch Laboratories). Con-
focal images were captured using a Zeiss 510 microscope. For
details on calbindin immunofluorescence quantification, see Sup-
plemental Experimental Procedures.
Cell Culture and Protease-Inhibitor Treatment
S2 cell transfection and luciferase assay were performed as de-
scribed previously (Jafar-Nejad et al., 2003). BE-2 human neuro-
blastoma cells were plated the day before transfection at 1 × 105
cells per well in 24-well plates. The following day, a HA-tagged Gfi-1
construct was transfected into BE-2 cells using Lipofectamine plus
(Invitrogen). Sixty to sixty-two hours later, the proteasome was in-
hibited using clasto-lactocystin β-lactone (20 M; Calbiochem) for
10–12 hr.
Pulse-Chase Experiments
Ataxin-1[82Q] lacking AHX domain was generated and cloned into
pxFLAG-CMV10 vector (Sigma). Other constructs and transfection
into the BE-2 cells are explained above. Metabolic labeling was
carried out by first starving the cells in methionine-free medium.
Thirty minutes later, this medium was removed, and cells were
pulsed in the same medium containing 50 Ci/ml L-[35S]methionine
for 1 hr. Cells were washed twice and incubated in medium supple-
mented with 150 g/ml unlabeled methionine. Cells were then
chased in the presence or absence of 20 M clasto-lactocystin
β-lactone and collected at various times. Whole-cell extracts were
obtained in TST buffer (50 mM Tris-HCl [pH 7.5], 0.15 M NaCl, and
0.5% Triton X-100) containing protease inhibitors and subjected to
immunoprecipitation with Gfi-1 antibody.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and two figures and can be found with this article online at http://
www.cell.com/cgi/content/full/122/4/633/DC1/.
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